CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples
<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least part...
Saved in:
Main Authors: | Ron Lee (Author), Sally Ullery (Author), Ron Thomason (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hematology Case Reports and Reviews - Peertechz Publications,
2020-05-01.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of CD38+ T-cell activation patterns determined by flow cytometry for prediction of classic Hodgkin lymphoma
by: Kelley Taylor, et al.
Published: (2020) -
Bone Marrow T Cells at the Center Stage in Immunological Memory
by: Francesca Di Rosa
Published: (2017) -
Neoplasm
Published: (2018) -
Bone Marrow Adipose Tissue: Formation; Function; and Impact on Health and Disease
by: Erica L. Scheller
Published: (2017) -
Bone Marrow Adiposity: Establishing Harmonized, Mechanistic and Multidisciplinary Approaches to Reach Clinical Translation
Published: (2020)